Kabra Drugs share news, announcements and annual reports
BSE: 524322Pharmaceuticals & BiotechnologySmall Cap
Share price at the BSE close on 30 Oct 2026. Previous close ₹15.72.
30 Oct: open ₹15.99, high ₹16.49, low ₹15.67
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹39 Cr3,225th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- 5.11
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 1.31
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- 28.0%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- 28.4%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026.
- 0.01
- Volume, BSEVolume. Shares traded on the last trading day. Volume in the glossary
- 59,920
Kabra Drugs share news and announcements
558 announcements, routine notices left out, newest first. Page 3 of 12.
Feb 2025
7 Feb · Board meeting
Meeting on 14 Feb 2025: quarterly results5 Feb · Announcement under Regulation 30 (LODR)-Allotment
4 Feb · Announcement under Regulation 30 (LODR)-Allotment
4 Feb · Board meeting
Jan 2025
3 Jan · Meeting
2 Jan · Meeting
Dec 2024
4 Dec · Board meeting
Nov 2024
25 Nov · Board meeting
Meeting on 4 Dec 20247 Nov · Board meeting
Meeting on 14 Nov 2024: quarterly results4 Nov · Board meeting
Oct 2024
21 Oct · Board meeting
Meeting on 4 Nov 202414 Oct · Management
14 Oct · Management
14 Oct · Meeting
1 Oct · Meeting
Sep 2024
30 Sep · Meeting
4 Sep · Meeting
3 Sep · Management
2 Sep · Meeting
Aug 2024
27 Aug · Board meeting
Meeting on 2 Sep 202414 Aug · Management
7 Aug · Board meeting
Meeting on 14 Aug 2024: quarterly results
Jul 2024
15 Jul · Announcement under Regulation 30 (LODR)-Change in Corporate Office Address
15 Jul · Announcement under Regulation 30 (LODR)-Change in Registered Office Address
8 Jul · Board meeting
Meeting on 12 Jul 2024
May 2024
30 May · Management
22 May · Board meeting
Meeting on 30 May 2024: audited results
Apr 2024
30 Apr · Regulation 40(9) & 40(10) Of The Securities Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations, 2015, As Amended ('Listing Regulations')
8 Apr · Compliance Certificate Under Regulation 7(3) Of The SEBI (LODR), Regulations 2015